CNGA3
Basic information
Region (hg38): 2:98346188-98398601
Previous symbols: [ "CNCG3", "ACHM2" ]
Links
Phenotypes
GenCC
Source:
- achromatopsia 2 (Strong), mode of inheritance: AR
- cone-rod dystrophy (Supportive), mode of inheritance: AD
- achromatopsia (Supportive), mode of inheritance: AR
- achromatopsia 2 (Strong), mode of inheritance: AR
- achromatopsia 2 (Definitive), mode of inheritance: AR
- achromatopsia 2 (Definitive), mode of inheritance: AR
- Leber congenital amaurosis 9 (Limited), mode of inheritance: AR
- CNGA3-related retinopathy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Achromatopsia 2; Leber congenital amaurosis | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 9662398; 11536077; 15059731; 15980212; 16961972; 18636117; 20454696; 21901789; 21911670; 21912902; 23362848; 25616768 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (88 variants)
- Achromatopsia 2 (32 variants)
- Achromatopsia (16 variants)
- Retinal dystrophy (14 variants)
- Cone dystrophy (2 variants)
- Abnormality of the eye (2 variants)
- Macular dystrophy (1 variants)
- Galactosylceramide beta-galactosidase deficiency (1 variants)
- CNGA3-related disorder (1 variants)
- Fabry disease (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CNGA3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 120 | 128 | ||||
missense | 44 | 46 | 205 | 13 | 309 | |
nonsense | 24 | 30 | ||||
start loss | 0 | |||||
frameshift | 24 | 29 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 11 | 9 | 20 | |||
non coding | 27 | 28 | 65 | |||
Total | 97 | 60 | 240 | 161 | 15 |
Highest pathogenic variant AF is 0.000394
Variants in CNGA3
This is a list of pathogenic ClinVar variants found in the CNGA3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-98346189-A-G | Achromatopsia 2 | Conflicting classifications of pathogenicity (Nov 01, 2022) | ||
2-98346191-A-G | Achromatopsia 2 | Uncertain significance (Jan 13, 2018) | ||
2-98346246-G-A | Achromatopsia 2 | Uncertain significance (Jan 12, 2018) | ||
2-98346285-C-T | Achromatopsia | Uncertain significance (Jun 14, 2016) | ||
2-98346286-C-T | Achromatopsia 2 | Benign (Jan 13, 2018) | ||
2-98346301-G-A | Achromatopsia 2 | Uncertain significance (Jan 13, 2018) | ||
2-98346507-G-C | Achromatopsia 2 | Uncertain significance (Jan 13, 2018) | ||
2-98346529-G-A | Achromatopsia 2 | Uncertain significance (Jan 13, 2018) | ||
2-98369938-G-C | Achromatopsia | Conflicting classifications of pathogenicity (Oct 12, 2021) | ||
2-98369976-A-T | Achromatopsia 2 | Uncertain significance (Apr 15, 2021) | ||
2-98369979-G-C | Uncertain significance (Jul 12, 2022) | |||
2-98369983-AG-A | Pathogenic (Apr 08, 2022) | |||
2-98369999-C-G | Pathogenic (Jan 12, 2022) | |||
2-98370002-C-A | Likely benign (Sep 01, 2022) | |||
2-98370023-C-G | Likely benign (Jul 06, 2022) | |||
2-98370025-A-G | Uncertain significance (Apr 04, 2022) | |||
2-98370032-G-T | Uncertain significance (Aug 05, 2021) | |||
2-98370034-C-T | Achromatopsia 2 • CNGA3-related disorder | Benign/Likely benign (Jan 22, 2024) | ||
2-98370037-C-G | Achromatopsia 2 | Pathogenic (Jul 03, 2023) | ||
2-98370041-C-T | Achromatopsia 2 | Uncertain significance (Apr 15, 2021) | ||
2-98370042-C-T | Achromatopsia 2 • Achromatopsia | Pathogenic (Nov 16, 2023) | ||
2-98370043-G-A | Achromatopsia 2 | Uncertain significance (Nov 27, 2023) | ||
2-98370047-T-C | not specified • Achromatopsia 2 | Benign (Jan 31, 2024) | ||
2-98370049-T-C | Uncertain significance (Oct 01, 2022) | |||
2-98370050-CA-C | Achromatopsia 2 | Pathogenic (Oct 04, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CNGA3 | protein_coding | protein_coding | ENST00000393504 | 7 | 52447 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.03e-20 | 0.00104 | 125612 | 0 | 136 | 125748 | 0.000541 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0368 | 404 | 402 | 1.01 | 0.0000257 | 4535 |
Missense in Polyphen | 119 | 124.98 | 0.95217 | 1443 | ||
Synonymous | -0.405 | 183 | 176 | 1.04 | 0.0000117 | 1392 |
Loss of Function | -0.397 | 28 | 25.8 | 1.08 | 0.00000139 | 301 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000428 | 0.000423 |
Ashkenazi Jewish | 0.00580 | 0.00577 |
East Asian | 0.000652 | 0.000653 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000326 | 0.000325 |
Middle Eastern | 0.000652 | 0.000653 |
South Asian | 0.000360 | 0.000359 |
Other | 0.000981 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Visual signal transduction is mediated by a G-protein coupled cascade using cGMP as second messenger. This protein can be activated by cyclic GMP which leads to an opening of the cation channel and thereby causing a depolarization of cone photoreceptors. Induced a flickering channel gating, weakened the outward rectification in the presence of extracellular calcium, increased sensitivity for L-cis diltiazem and enhanced the cAMP efficacy of the channel when coexpressed with CNGB3 (By similarity). Essential for the generation of light-evoked electrical responses in the red-, green- and blue sensitive cones. {ECO:0000250, ECO:0000269|PubMed:10888875}.;
- Disease
- DISEASE: Achromatopsia 2 (ACHM2) [MIM:216900]: An autosomal recessive, ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus. {ECO:0000269|PubMed:11536077, ECO:0000269|PubMed:14757870, ECO:0000269|PubMed:15712225, ECO:0000269|PubMed:15743887, ECO:0000269|PubMed:18521937, ECO:0000269|PubMed:24903488, ECO:0000269|PubMed:26493561, ECO:0000269|PubMed:9662398}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- cAMP signaling pathway - Homo sapiens (human);Olfactory transduction - Homo sapiens (human);NO-cGMP-PKG mediated Neuroprotection;Visual signal transduction: Cones
(Consensus)
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- loftool
- 0.0506
- rvis_EVS
- -0.66
- rvis_percentile_EVS
- 16.12
Haploinsufficiency Scores
- pHI
- 0.298
- hipred
- N
- hipred_score
- 0.342
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.296
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cnga3
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); taste/olfaction phenotype;
Gene ontology
- Biological process
- cation transport;signal transduction;visual perception;response to corticosteroid;response to magnesium ion;response to cAMP;inorganic cation import across plasma membrane
- Cellular component
- cytoplasm;plasma membrane;dendrite;axon initial segment;perikaryon;glial cell projection;transmembrane transporter complex
- Molecular function
- intracellular cAMP-activated cation channel activity;intracellular cGMP-activated cation channel activity;protein C-terminus binding;ligand-gated ion channel activity;cGMP binding